Shahnawaz Khan Selected Research

Shahnawaz Khan Research Topics

2	Infections 08/2023 - 07/2019
2	Neoplasms (Cancer) 09/2014 - 06/2010
1	Spontaneous Fractures (Pathological Fracture) 04/2024
1	Wounds and Injuries (Trauma) 09/2023
1	Osteolysis 08/2023
1	Open Fractures (Compound Fracture) 08/2023
1	Type 2 Diabetes Mellitus (MODY) 09/2020
1	Insulin Resistance 09/2020
1	Congenital Abnormalities (Deformity) 07/2019
1	Hallux Valgus 07/2019
1	Hypersensitivity (Allergy) 07/2019
1	Pneumonia (Pneumonitis) 01/2017
1	Deafness (Deaf Mutism) 05/2011
1	Sensorineural Hearing Loss 05/2011
1	Hearing Loss (Hearing Impairment) 05/2011
1	Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis) 04/2006
1	Disease Progression 04/2006
1	Ectodermal Dysplasia (Aplasia Cutis Congenita) 01/2005

1	Polypropylenes (Polypropylene)IBA 04/2024
1	Polyurethanes (Polyurethane)IBA 09/2023
1	Hypoglycemic Agents (Hypoglycemics)IBA 09/2020
1	AdiponectinIBA 09/2020
1	Folic Acid (Vitamin M)FDA LinkGeneric 09/2020
1	mecobalamin (methylcobalamin)IBA 09/2020
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 09/2020
1	Insulin (Novolin)FDA Link 09/2020
1	LipidsIBA 09/2020
1	TitaniumIBA 07/2019
1	AlloysIBA 07/2019
1	MagnesiumIBA 07/2019
1	LigandsIBA 01/2017
1	OxindolesIBA 01/2017
1	Phosphodiesterase 5 InhibitorsIBA 05/2011
1	Sildenafil Citrate (Viagra)FDA Link 05/2011
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 05/2011
1	Carbolines (Beta-Carbolines)IBA 06/2010
1	DNA (Deoxyribonucleic Acid)IBA 04/2006
1	Cathepsin DIBA 04/2006
1	Edar ReceptorIBA 01/2005

1	Negative-Pressure Wound Therapy 09/2023
1	Surgical Amputation (Amputations) 08/2023
1	Artificial Limbs (Artificial Limb) 08/2023
1	Absorbable Implants 07/2019
1	Osteotomy 07/2019
1	Radiotherapy 09/2014